The Initial Public Offering (IPO) of Fabtech Technologies Cleanrooms Limited opened for subscription on Friday, January 3, 2025. The IPO aims to raise ₹27.74 crore through a fresh issue of 32.64 lakh shares. This offering is an opportunity for investors to buy shares of a company specializing in cleanroom solutions for pharmaceutical, healthcare, and biotechnology sectors.
Key Details of Fabtech Technologies Cleanrooms IPO
- Price Band: ₹80 to ₹85 per share
- Issue Size: 32,64,000 equity shares
- Minimum Investment: One lot of 1600 shares, costing ₹1,36,000 at the upper price band
- Issue Period: January 3 to January 7, 2025
- Listing Exchange: BSE SME
The company raised ₹7.89 crore from anchor investors on Thursday, January 2, 2025, one day before the IPO opened for public subscription.
On the first day, the IPO witnessed strong demand, getting fully subscribed quickly. The overall subscription stood at 2.52 times, with the retail investor portion subscribed 4.52 times. Non-institutional investors subscribed 1.2 times, while the qualified institutional buyers (QIBs) portion was yet to pick up.
The Grey Market Premium (GMP) for Fabtech Technologies Cleanrooms shares indicates robust interest. As of January 3, 2025, the GMP stood at ₹50, suggesting a potential listing price of ₹135 per share. This represents a premium of 59% over the upper IPO price of ₹85.
About Fabtech Technologies Cleanrooms
Fabtech Technologies Cleanrooms specializes in creating modular panels and doors that are pre-engineered and pre-fabricated, designed specifically for cleanroom environments. These cleanrooms maintain controlled environments with low levels of pollutants, making them essential for pharmaceutical, biotech, and healthcare industries.
Investors can apply for the IPO through their brokers or online trading platforms. Applications are accepted in multiples of 1600 shares.
Listing Date and Allotment
Post the closure of the IPO on January 7, 2025, the allotment of shares is expected to take place on January 8, 2025. The shares are likely to be listed on the BSE SME platform on January 10, 2025.
This IPO offers an exciting opportunity to invest in a growing company catering to critical industries. Investors are advised to track the subscription status and GMP trends for informed decision-making.
